Articles - Setterwalls

Articles

News to help keep you a step ahead.

Our latest articles

Stay up to date on current topics by reading articles written by our experienced lawyers. Search for the area of expertise that you are interested in.

Category Activities in the public sectorAutomotive industryBanking and financeBuilding & constructionChina deskCommerce & consumerCommercial agreementsCompliance & InvestigationsConstruction contract lawCorporate lawCOVID-19 | CoronavirusetDispute resolutionEmployment and pension lawEnergy & commoditiesEnvironmental lawEquity Capital MarketsEU & Competition lawFinTechInfrastructureInsolvency, restructuring and bankruptcyIntellectual property, marketing and media lawIT law and data protectionIT, technology & telecomsLife SciencesMergers & Acquisitions, M&APrivate EquityPublic procurementReal Estate LawTax lawTransport

Year202520242023202220212020201920182017201620152014

EU Anti-Tax Avoidance Directive III: A seven-step approach to the Unshell Directive

Article | 8 December 2023

M & A

“A combination of professional excellence, personal engagement and a tight relationship.”

Legal 500
Energy & commodities

“A full-service firm with an excellent track record in energy services and permitting.”

Legal 500
Tax law

“All-round knowledge and international network.”

Chambers Europe
Dispute resolution

“Clear, crisp, short and no nonsense advice.”

Legal 500
M & A

“Dedicated, enduring staff with strong attention for details”

Legal 500

News to help keep you a step ahead.

Our latest articles

EU Anti-Tax Avoidance Directive III: A seven-step approach to the Unshell Directive

EU Regulation for Non-Agri Geographical Indications Now in Force

Pharmaceutical companies fined €13.4 million by the European Commission for price fixing

Life Sciences Report December 2023

New timeline for EUDAMED

Switch of biological medicinal products

Proposal for new Directive and Regulation on medicinal products for human use

Preparing for the NIS 2 Directive: Impacts on the health sector

Pharmaceutical marketing compliance

National exceptions for relabelling with new safety features – increased legal certainty and patient safety?